$3.06 Billion is the total value of BRAIDWELL LP's 82 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 47.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Sell | EXACT SCIENCES CORPnote 0.375% 3/0 | $134,691,036 | +9.7% | 131,000,000 | -5.8% | 4.40% | +8.7% | |
| Sell | BRIDGEBIO PHARMA INCnote 2.500% 3/1 | $101,094,132 | -4.8% | 128,338,000 | -10.5% | 3.30% | -5.7% | |
| Sell | ALPHATEC HLDGS INCnote 0.750% 8/0 | $82,406,723 | -23.8% | 70,750,000 | -30.1% | 2.69% | -24.5% | |
| GKOS | Sell | GLAUKOS CORP | $74,371,154 | -17.8% | 1,044,392 | -42.2% | 2.43% | -18.6% |
| XENE | Sell | XENON PHARMACEUTICALS INC | $70,391,591 | -8.0% | 1,828,353 | -14.4% | 2.30% | -8.8% |
| ISRG | Sell | INTUITIVE SURGICAL INC | $42,339,011 | -25.7% | 123,820 | -44.5% | 1.38% | -26.4% |
| LEGN | Sell | LEGEND BIOTECH CORPsponsored ads | $38,401,458 | +32.3% | 556,301 | -7.6% | 1.26% | +31.1% |
| BIIB | Sell | BIOGEN INC | $34,735,179 | -43.4% | 121,942 | -44.8% | 1.14% | -43.9% |
| KIDS | Sell | ORTHOPEDIATRICS CORP | $33,378,971 | -24.6% | 761,208 | -23.8% | 1.09% | -25.2% |
| OM | Sell | OUTSET MED INC | $31,938,248 | -1.1% | 1,460,368 | -16.8% | 1.04% | -2.0% |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $30,085,382 | +13.8% | 2,901,194 | -11.3% | 0.98% | +12.7% |
| KRYS | Sell | KRYSTAL BIOTECH INC | $28,340,242 | +1.7% | 241,399 | -30.6% | 0.93% | +0.8% |
| Sell | NEOGENOMICS INCnote 1.250% 5/0 | $26,302,500 | -15.0% | 28,000,000 | -15.2% | 0.86% | -15.9% | |
| PEN | Sell | PENUMBRA INC | $22,654,287 | -24.1% | 65,844 | -38.5% | 0.74% | -24.8% |
| Sell | HILLEVAX INC | $21,474,539 | -19.8% | 1,249,246 | -22.9% | 0.70% | -20.5% | |
| TERN | Sell | TERNS PHARMACEUTICALS INC | $16,120,580 | -31.8% | 1,842,352 | -7.7% | 0.53% | -32.4% |
| LUNG | Sell | PULMONX CORP | $13,101,636 | +0.7% | 999,362 | -14.1% | 0.43% | -0.2% |
| CRNX | Sell | CRINETICS PHARMACEUTICALS IN | $11,718,622 | -63.9% | 650,312 | -67.8% | 0.38% | -64.2% |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $8,693,781 | -48.3% | 240,625 | -46.8% | 0.28% | -48.7% |
| ESPR | Sell | ESPERION THERAPEUTICS INC NE | $1,245,369 | -35.3% | 895,949 | -26.0% | 0.04% | -35.9% |
| Exit | AVALO THERAPEUTICS INC | $0 | – | -247,254 | -100.0% | -0.01% | – | |
| IMTX | Exit | IMMATICS N.V | $0 | – | -322,287 | -100.0% | -0.07% | – |
| SILK | Exit | SILK RD MED INC | $0 | – | -63,331 | -100.0% | -0.08% | – |
| Exit | SUPERNUS PHARMACEUTICALSnote 0.625% 4/0 | $0 | – | -6,500,000 | -100.0% | -0.22% | – | |
| TMDX | Exit | TRANSMEDICS GROUP INC | $0 | – | -98,459 | -100.0% | -0.25% | – |
| ARGX | Exit | ARGENX SEsponsored adr | $0 | – | -24,600 | -100.0% | -0.30% | – |
| Exit | ARCELLX INC | $0 | – | -333,800 | -100.0% | -0.34% | – | |
| PACB | Exit | PACIFIC BIOSCIENCES CALIF IN | $0 | – | -1,097,300 | -100.0% | -0.42% | – |
| MRSN | Exit | MERSANA THERAPEUTICS INC | $0 | – | -3,355,805 | -100.0% | -0.46% | – |
| STE | Exit | STERIS PLC | $0 | – | -95,694 | -100.0% | -0.60% | – |
| GMED | Exit | GLOBUS MED INCcl a | $0 | – | -335,200 | -100.0% | -0.63% | – |
| SNDX | Exit | SYNDAX PHARMACEUTICALS INC | $0 | – | -920,049 | -100.0% | -0.64% | – |
| BLU | Exit | BELLUS HEALTH INC NEW | $0 | – | -4,126,194 | -100.0% | -0.98% | – |
| Exit | IONIS PHARMACEUTICALS INCnote 0.125%12/1 | $0 | – | -36,533,000 | -100.0% | -1.12% | – | |
| AMGN | Exit | AMGEN INC | $0 | – | -161,500 | -100.0% | -1.29% | – |
| Exit | EXACT SCIENCES CORPnote 0.375% 3/1 | $0 | – | -48,300,000 | -100.0% | -1.49% | – | |
| Exit | NUVASIVE INCnote 1.000% 6/0 | $0 | – | -51,500,000 | -100.0% | -1.69% | – | |
| ISEE | Exit | IVERIC BIO INC | $0 | – | -3,714,672 | -100.0% | -2.98% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GUARDANT HEALTH INC | 4 | Q3 2023 | 6.3% |
| EXACT SCIENCES CORP | 4 | Q3 2023 | 4.4% |
| NOVOCURE LTD | 4 | Q3 2023 | 3.9% |
| NANOSTRING TECHNOLOGIES INC | 4 | Q3 2023 | 4.0% |
| NEVRO CORP | 4 | Q3 2023 | 3.4% |
| BRIDGEBIO PHARMA INC | 4 | Q3 2023 | 3.5% |
| ALPHATEC HLDGS INC | 4 | Q3 2023 | 3.6% |
| GLAUKOS CORP | 4 | Q3 2023 | 3.0% |
| VAXCYTE INC | 4 | Q3 2023 | 2.8% |
| XENON PHARMACEUTICALS INC | 4 | Q3 2023 | 2.5% |
View BRAIDWELL LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-02-14 |
| SC 13G | 2023-02-14 |
View BRAIDWELL LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.